Capsular bag performance of a novel hydrophobic acrylic single-piece intraocular lens : Two-year results of a randomised controlled trial
PURPOSE: To determine the visual outcome, intraocular lens (IOL) stability and posterior capsule opacification (PCO) rate of a hydrophobic acrylic intraocular lens.
SETTING: Vienna Institute for Research in Ocular Surgery, Hanusch Hospital, Vienna, Austria.
DESIGN: This double-masked randomised study included patients who underwent standard cataract surgery.
METHOD: Patients received either the hydrophobic acrylic IOL (iPure, PhysIOL) or the hydrophobic acrylic control IOL (Tecnis ZCB00, Johnson&Johnson). Subjective refraction, uncorrected and corrected distance visual acuity (UDVA, CDVA), IOL tilt and decentration (Purkinje meter) and PCO intensity using retroillumination images with automated image analysis (automated quantification of after-cataract, AQUA), were evaluated for both groups 2 years after surgery.
RESULTS: A total number of 31 patients completed the 2-year follow-up, 16 in the study group and 15 in the control group. The CDVA was 0.0 logMAR (standard deviation - SD: 0.1) for the study IOL and 0.1 logMAR (SD: 0.2) for the control IOL, p = 0.001. The AQUA PCO score for the study group was 2.1 and 1.4 for the control group, p = 0.44. Mean IOL tilt was 2.9° (SD: 1.8) in the study group and 5.0° (SD: 4.5) in the control group, whilst the mean decentration was 0.37 mm (SD: 0.18) and 0.45 mm (SD: 0.3), p = 0.610.
CONCLUSION: The studied parameters revealed a good performance for both IOLs. Both IOLs had good CDVA, a small amount of tilt and decentration and none of the patients required laser capsulotomies during the follow-up time of 2 years after surgery.Presented at the 37th ESCRS Congress Paris, France, September 2019.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
European journal of ophthalmology - 31(2021), 5 vom: 29. Sept., Seite 2377-2382 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fișuș, Andreea D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical tests |
|---|
| Anmerkungen: |
Date Completed 03.12.2021 Date Revised 28.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1177/1120672120960591 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315639571 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315639571 | ||
| 003 | DE-627 | ||
| 005 | 20231225155344.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/1120672120960591 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1052.xml |
| 035 | |a (DE-627)NLM315639571 | ||
| 035 | |a (NLM)32993380 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fișuș, Andreea D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Capsular bag performance of a novel hydrophobic acrylic single-piece intraocular lens |b Two-year results of a randomised controlled trial |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.12.2021 | ||
| 500 | |a Date Revised 28.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a PURPOSE: To determine the visual outcome, intraocular lens (IOL) stability and posterior capsule opacification (PCO) rate of a hydrophobic acrylic intraocular lens | ||
| 520 | |a SETTING: Vienna Institute for Research in Ocular Surgery, Hanusch Hospital, Vienna, Austria | ||
| 520 | |a DESIGN: This double-masked randomised study included patients who underwent standard cataract surgery | ||
| 520 | |a METHOD: Patients received either the hydrophobic acrylic IOL (iPure, PhysIOL) or the hydrophobic acrylic control IOL (Tecnis ZCB00, Johnson&Johnson). Subjective refraction, uncorrected and corrected distance visual acuity (UDVA, CDVA), IOL tilt and decentration (Purkinje meter) and PCO intensity using retroillumination images with automated image analysis (automated quantification of after-cataract, AQUA), were evaluated for both groups 2 years after surgery | ||
| 520 | |a RESULTS: A total number of 31 patients completed the 2-year follow-up, 16 in the study group and 15 in the control group. The CDVA was 0.0 logMAR (standard deviation - SD: 0.1) for the study IOL and 0.1 logMAR (SD: 0.2) for the control IOL, p = 0.001. The AQUA PCO score for the study group was 2.1 and 1.4 for the control group, p = 0.44. Mean IOL tilt was 2.9° (SD: 1.8) in the study group and 5.0° (SD: 4.5) in the control group, whilst the mean decentration was 0.37 mm (SD: 0.18) and 0.45 mm (SD: 0.3), p = 0.610 | ||
| 520 | |a CONCLUSION: The studied parameters revealed a good performance for both IOLs. Both IOLs had good CDVA, a small amount of tilt and decentration and none of the patients required laser capsulotomies during the follow-up time of 2 years after surgery.Presented at the 37th ESCRS Congress Paris, France, September 2019 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a IOLs < Lens / Cataract | |
| 650 | 4 | |a clinical tests | |
| 650 | 4 | |a postoperative anterior segment problems | |
| 650 | 4 | |a pre-op medical testing | |
| 700 | 1 | |a Hirnschall, Nino D |e verfasserin |4 aut | |
| 700 | 1 | |a Maedel, Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a Fichtenbaum, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Draschl, Petra |e verfasserin |4 aut | |
| 700 | 1 | |a Findl, Oliver |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of ophthalmology |d 1996 |g 31(2021), 5 vom: 29. Sept., Seite 2377-2382 |w (DE-627)NLM012606944 |x 1724-6016 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2021 |g number:5 |g day:29 |g month:09 |g pages:2377-2382 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/1120672120960591 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2021 |e 5 |b 29 |c 09 |h 2377-2382 | ||